Compassion Center urges media outlets to report accurately on the DEA's active cannabis rescheduling hearings, emphasizing the importance of factual coverage during this pivotal regulatory process.

U.S. Sen. Tim Kaine of Virginia and colleagues introduced the bipartisan, bicameral Combating Illicit Xylazine Act last week.

N.H., met with law enforcement officials in Manchester Tuesday to discuss a bipartisan bill she has reintroduced that would ...

The government is planning to bring painkiller Tapentadol and epilepsy drug Pregabalin under strict control and monitoring to ...

The bipartisan Combating Illicit Xylazine Act has been reintroduced in the House by author Rep. Jimmy Panetta that would list xylazine as a Schedule III controlled substance while protecting the ...

A legal loophole is allowing children who access social media to see enticing advertisements for marijuana with potentially ...

A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...

Data released Friday shows the number of overdoses in the state's two largest cities continued to trend "significantly lower" in January, though officials warn that could change with a powerful drug ...

U.S. Senator Tim Kaine (D-VA), alongside his colleagues, introduced the bipartisan, bicameral Combating Illicit Xylazine Act.

A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...

A federal appellate court has rejected the latest effort by a Washington State doctor who is seeking to legally use ...

Republicans have reintroduced bills to address the fentanyl crisis. The bills would increase criminal penalties and ...